BACK TO TOP
KSE100
177,382.57
610.39
(0.35%)
KSE100PR
52,412.25
180.35
(0.35%)
ALLSHR
106,289.82
141.72
(0.13%)
KSE30
51,822.39
245.89
(0.48%)
KMI30
255,823.27
1649.18
(0.65%)
BKTI
48,432.52
109.40
(0.23%)
OGTI
35,759.50
-46.88
(-0.13%)
KMIALLSHR
68,759.73
47.95
(0.07%)
PSXDIV20
81,338.92
172.84
(0.21%)
UPP9
64,098.12
696.49
(1.10%)
NITPGI
47,890.77
363.43
(0.76%)
NBPPGI
51,365.48
315.36
(0.62%)
MZNPI
32,172.39
308.64
(0.97%)
JSMFI
40,207.59
-178.06
(-0.44%)
ACI
22,582.84
57.83
(0.26%)
JSGBKTI
75,251.40
95.52
(0.13%)
HBLTTI
19,418.93
19-11-2026
6.32
(0.03%)
MII30
23,217.99
125.17
(0.54%)
Liven Pharma Limited
PHARMACEUTICALS
Rs.52.40
4.76
(9.99%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Nov 20, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
49.99
High
52.40
Low
45.05
Volume
3,525,378
CIRCUIT BREAKER
42.88 — 52.40
DAY RANGE
45.05 — 52.40
52-WEEK RANGE ^
27.82 — 70.68
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
47.64
VAR
22.00
HAIRCUT
27.50
P/E Ratio (TTM) **
N/A
1-Year Change * ^
-14.10%
YTD Change * ^
0.83%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Liven Pharma Limited was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted into a public limited company on April 30, 1992 under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act, 2017). The principal activity of the Company is the manufacturing of pharmaceuticals and allied products.

KEY PEOPLE
Kashif Hussain SiddiquieCEO
Atif Hussain SiddiqiChairman
Muhammad SaeedCompany Secretary
ADDRESS

49-Km, Multan Road, Lahore

WEBSITE

www.liven-pharma.com

REGISTRAR

F.D. Registrar Services SMC (Pvt.) Ltd., 1705,17th Floor, Saima Trade Tower A, I.I. Chundrigar Road, Karachi

AUDITOR

M/s Reanda Haroon Zakaria Aamir Salman Rizwan & Company, Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
5,923,315.23
Shares
113,040,367
Face Value
10.00
Free Float
11,304,037
Free Float
10.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Nov 2, 2026Financial Results for the Quarter Ended September 30-2026 View   PDF
Oct 5, 2026financial results for the Year Ended June 30, 2026 View   PDF
Oct 5, 2026Transmission of Annual Report for the Year Ended June 30, 2026 View   PDF
Apr 29, 2026Financial Results for the 3rd Quarter Ended 31st March 2026 View   PDF
Mar 9, 2026Condensed Interim Financial Statements for the Half Year ended December 31, 2025 (with shariah compliant disclosure) View   PDF
DateTitleDocument
Nov 12, 2026General Meetings / Briefing Sessions View   PDF
Oct 27, 2026BOARD MEETING FOR 1st Quarter Financials 2027 View   PDF
Oct 26, 2026Certified True Copy of Resolution Passed in Annual General Meeting Held 26th October 2026 View   PDF
Oct 5, 2026Notice of Annual General Meeting
REVISED
View   PDF
Oct 5, 2026Notice of Annual General Meeting
REVOKED
View   PDF
DateTitleDocument
Nov 12, 2026Notice of Corporate Briefing Session View   PDF
Oct 5, 2026Correction Clarification Regarding Annual Report 2026 View   PDF
Oct 5, 2026Annual Free-Float Certificate duly verified by the Auditor
REVOKED
View   PDF
Aug 27, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jul 15, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales105,807127,272245,093
Profit after Taxation(31,139)(584,460)41,744(12,327)
EPS(0.28)(7.11)1.04(1.02)
Q1 2027Q3 2026Q2 2026Q1 2026
Sales14,29329,24754,5598,821
Profit after Taxation(7,372)(3,956)28,210(30,157)
EPS(0.07)(0.03)(0.30)(0.28)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)25.1814.1125.46
Net Profit Margin (%)(29.43)(459.22)17.03
EPS Growth (%)96.06(781.03)202.3513.56
PEG(1.51)0.010.04(1.06)

Payouts

Financial Reports